This not-to-be-missed two day D4 conference comprises keynote presentations D

Transcription

This not-to-be-missed two day D4 conference comprises keynote presentations D
D4 – DEVICES FOR DIAGNOSTICS AND DRUG DELIVERY
26-27th November 2014
Dunedin, New Zealand
This not-to-be-missed two day D4 conference comprises keynote presentations
from international and national speakers, covering several major themes. In
addition, there is opportunity for a limited number of oral presentations in
addition to posters submitted by attendees. The Conference will provide
opportunity for networking among registrants who will be coming from
industry, research institutes, government agencies and universities, and sharing
ideas on the latest developments in devices for diagnostics and drug delivery.
D4 Devices
Improving the performance of diagnostic devices and combination drug-device
products
Centre for Bioengineering & Nanomedicine:
Professor David Grainger, Dept of Pharmaceutics and Pharmaceutical Chemistry,
University of Utah, United States of America
Diagnostic Devices
Targeted delivery vehicles for in situ diagnosis and screening of early malignancy
in the GI tract
Professor Abraham Rubinstein, School of Pharmacy Institute for Drug Research, Hebrew
University of Jerusalem, Israel
Circulating microRNAs as diagnostic and prodiagnostic markets for cardiovascular
disease
Dr Rajesh Katare, Dept of Physiology, University of Otago, Dunedin, NZ
Remote location parasite diagnostics to aid in monitoring anthelmintic drug
efficacy
Dr Stephen Sowerby, Dept of Biochemistry, University of Otago, Dunedin, NZ
TBA
Professor Mauro Farella, Dept of Oral Sciences, University of Otago, Dunedin, NZ
Devices for Drug Delivery
Micro-needle devices for drug, macromolecule and vaccine delivery to and through
skin
Professor James Birchall School of Pharmacy & Pharmaceutical Sciences, Cardiff
University, UK
CMDT
Magnetic targeting and activation for controlled delivery and release
Professor Quentin Pankhurst University College, London, UK
Needle-free delivery and diagnosis using fluid jets: capabilities and challenges
Associate Professor Andrew Taberner, Auckland Bioengineering Institute, Auckland, NZ
Pulmonary delivery of spray-dried powders using dry powder inhalers
Dr Shyamal Das, School of Pharmacy, University of Otago, Dunedin, NZ
www.bioactives.otago.ac.nz
Translation and Its Challenges
Regulatory considerations for diagnostics and devices
Dr Stewart Jessamine, Medsafe, Wellington, NZ
Bringing affordable immunodiagnostics for near-patient care
Dr Anand Kumble, Pictor, Auckland, NZ
TBA
Associate Professor George Dias, Dept of Anatomy, University of Otago, Dunedin, NZ
Lessons from US Medtech innovation
Chris Somogyi, Callaghan Innovation, Auckland, NZ
Submitted paper presentations will also be made in all symposia
www.bioactives.otago.ac.nz